Latest News

Faculty Spotlight: Professor Mitchell Sutter, Ph.D.

Professor Mitchell Sutter has wanted to be a bioengineer ever since he watched the American science fiction and action television series “The Six Million Dollar Man” as a teenager. After a NASA test flight accident, the series’ main character and former astronaut USAF Colonel Steve Austin is rebuilt with superhuman strength, speed, and vision due to bionic implants. He uses his enhanced abilities to work for the Office of Scientific Intelligence as a secret agent. Understandably, the show must have caught the imagination of many.

CBS Welcomes Three New Faculty Members for 2021-2022 Year

For the 2021-2022 academic year, the college is proud to welcome three new members to its faculty. Below you’ll learn more about the research interest of each faculty member, and what brought them to UC Davis.

UC Davis Launches Neuroscience Consortium

September 29, 2021

Today the University of California, Davis, officially launched a consortium called the UC Davis Neuroscience Consortium (UCDNC) to leverage the strength, breadth and depth of one of the largest neuroscience communities in the world. The consortium brings together nearly 300 researchers from eleven centers and 41 departments — integrating biologists, chemists, social scientists, engineers, computer scientists and clinicians.

Hippocampus Is the Brain’s Storyteller

People love stories. We find it easier to remember events when they are part of an overarching narrative. But in real life, the chapters of a story don’t follow smoothly one from another. Other things happen in between. A new brain imaging study from the Center for Neuroscience at the University of California, Davis, shows that the hippocampus is the brain’s storyteller, connecting separate, distant events into a single narrative. The work is published Sept. 29 in Current Biology.

Whistler Lab Identifies a Potentially Safer Approach to Opioid Drug Development

Opioids are powerful painkillers, but their use is hindered because patients become tolerant to them, requiring higher and higher doses, and overdoses can cause respiratory depression and death. A recent study from researchers at the UC Davis Center for Neuroscience contradicts existing thinking about how opioid drugs cause tolerance and respiratory depression, and suggests a new, balanced approach to developing safer analgesics. The work was published July 13 in Neuropsychopharmacology.

Evolutionary Thinking: a New Perspective on How Our Brains Control Behavior Takes Evolution into Account

We watch a ball as it falls into our glove. We hear a strange sound in another part of the house and listen intently. In neuroscience, the act of narrowing our senses in response to an environmental event is called “attention,” and it is understood that when we attend to a stimulus, we lose the ability to focus on other surrounding inputs.

Brain Stimulators Could Treat Neurological Diseases

By Noah A Pflueger-Peters  

While drugs help patients mitigate the most extreme conditions of mental illnesses like schizophrenia or depression, they often don’t address the cognitive deficits many diseases cause, such as memory loss, low attention span and impaired decision-making.

Center for Neuroscience Faculty Discusses 'Did this Memory Really Happen?' on Every Little Thing Podcast

Charan Ranganath, Ph.D., UC Davis professor of psychology at the Center for Neuroscience, was a guest on the Every Little Thing podcast episode Memory Game: Did This Meal Really Happen? on May 10, 2021. Dr. Ranganath spoke with hosts Annette Heist and Jorge Just about how we form memories and the tricky nature of deciding about whether a memory is "true." Listen to the full episode here.

Professor Charan Ranganath Featured on NPR's Life Kit Episode: You're Probably Not As Open-Minded As You Think. Here's How To Practice

NPR's Life Kit host Rose Eveleth interviewed UC Davis neuroscientist Charan Ranganath, a psychology professor and Director of the Memory and Plasticity Program at the Center for Neuroscience for the podcast episode You're Probably Not As Open-Minded As You Think. Here's How to Practice on May 3, 2021.  Dr. Ranganath discussed why being calm and curious helps us be more open-minded. Read or listen to the full story here.

UC Davis Receives $15 Million Grant to Study the Effects of Maternal Infection on Risk for Psychiatric Illness in Offspring

The National Institute of Mental Health (NIMH) has awarded a $15.7 million grant to the UC Davis Silvio O. Conte Center, one of only 15 Conte Centers nationwide.

Psychiatric illnesses and neurodevelopmental disorders, including schizophrenia, affect 15-20 percent of the population worldwide, yet current treatments are at best only partially effective. The UC Davis Conte Center was first established in 2016 through the Center for Neuroscience to determine how maternal infection increases risk for these disorders and to identify new targets for novel treatments.

Sloan Fellowships for UC Davis Mathematician, Neuroscientist

Sloan Fellowships for UC Davis Mathematician, Neuroscientist

Two faculty members at the University of California, Davis, have been named as 2021 Sloan Research Fellows by the Alfred P. Sloan Foundation. Considered one of the most prestigious fellowships given to young researchers, the Sloan fellowship includes $75,000 over two years to support the fellow’s research.

New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression

New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression By Andy Fell on December 9, 2020 in Human & Animal Health  

A non-hallucinogenic version of the psychedelic drug ibogaine has been developed by David Olson and colleagues at the UC Davis Department of Chemistry. The new compound shows potential for treating psychiatric disorders including addiction in animal models and may work by increasing connectivity between nerve cells.